| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/12/2002 | EP1212405A2 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 06/12/2002 | EP1212404A2 Isolation of muscle-derived stem cells and uses therefore |
| 06/12/2002 | EP1212376A1 Synthetic vegetal melanins, process for their production and compositions containing thereof |
| 06/12/2002 | EP1212366A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 06/12/2002 | EP1212364A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212349A1 Recombinant subunit vaccine |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212342A2 18 human secreted proteins |
| 06/12/2002 | EP1212331A1 28-epirapalogs |
| 06/12/2002 | EP1212329A2 Amine derivatives of benzo[4,5]thieno[2,3-d]pyrimidine |
| 06/12/2002 | EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 06/12/2002 | EP1212327A2 Pyrazolopyrimidines as therapeutic agents |
| 06/12/2002 | EP1212326A1 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 06/12/2002 | EP1212323A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212309A1 Caspase inhibitor |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212295A1 SUBSTITUTED $g(a)-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 06/12/2002 | EP1212120A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212086A1 Immunological tolerance-induction agent |
| 06/12/2002 | EP1212085A2 Compositions for stimulating cytokine secretion and inducing an immune response |
| 06/12/2002 | EP1212083A1 Oral recombinant lactobacilli vaccines |
| 06/12/2002 | EP1212074A1 Hybrid peptides modulate the immune response |
| 06/12/2002 | EP1212071A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 06/12/2002 | EP1212067A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 06/12/2002 | EP1212063A2 Topical azathioprine for the treatment of oral autoimmune diseases |
| 06/12/2002 | EP1212062A1 Use of thienopyrimidines |
| 06/12/2002 | EP1212058A1 Topical treatment for prevention of ocular infections |
| 06/12/2002 | EP1212057A1 Extended duration light activated cancer therapy |
| 06/12/2002 | EP1044000B1 Combination therapy for the treatment of aids |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP1028947B1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 06/12/2002 | EP1023263B1 Novel vitamin d analogues |
| 06/12/2002 | EP0966437B1 5-aroylnaphthalene derivatives |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | EP0888327B1 Benzopyran derivatives having leukotriene-antagonistic action |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0873362B1 PROCESS FOR ISOLATING IgG AND IgA |
| 06/12/2002 | EP0777677B1 Methods of identifying compounds useful for treating autoimmune diseases |
| 06/12/2002 | EP0768881B1 Anti-hiv triple combination comprising zidovudine, lamivudine and loviride |
| 06/12/2002 | EP0722452B1 Nf-at polypeptides and polynucleotides |
| 06/12/2002 | EP0697881B1 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent |
| 06/12/2002 | CN1353764A Method for selecting improved vectors |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353702A Adamantane derivatives |
| 06/12/2002 | CN1353701A Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| 06/12/2002 | CN1353698A Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353692A Betz 2-adrenoceptor agonists |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353613A Pharmaceutical compositions |
| 06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353575A i(in Vitro) induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 06/12/2002 | CN1352990A Bio-active substance of antrodia camphorata mycelia, its preparing process and its composition |
| 06/12/2002 | CN1352976A Immunoregulator for resisting I-type allergic reaction and its preparing process |
| 06/12/2002 | CN1352896A Process for extracting genistein as anticancer and oncogenic dioxanin resistant substance from fermented soybean |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403805 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatves |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403790 Suspending and dissolving epinastine base in water by adding aqueous hydrochloric acid at specified ph, extracting solution obtained with organic water-immiscible solvent, removing solvent, adjusting ph to precipitate product, drying |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403613 Anti-inflammatory agent that reduces levels of cytokines (including tumor necrosis factor) |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403608 3-Substituted isoquinolin-1-yl derivatives |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403586 Interleukin inhibitors |
| 06/11/2002 | US6403560 Extracting hyaluronic acid together with a protein from chicken comb, mammalian skin or mammalian organ; |
| 06/11/2002 | US6403559 C-kit ligand-based method for expanding peripheral blood cell levels |
| 06/11/2002 | US6403555 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/11/2002 | US6403104 Hapten-conjugated mammalian cells and methods of making and using thereof |
| 06/11/2002 | US6403099 Conjugates formed from heat shock proteins and oligo-or polysaccharides |
| 06/11/2002 | US6403095 Treatment of primary and metastatic neoplastic diseases with HSP70-peptide complexes |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
| 06/11/2002 | US6403079 Using polypeptide |
| 06/11/2002 | CA2232267C Novel imidazole lipoxygenase inhibitors |
| 06/11/2002 | CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | CA2057441C Synthetic conversion of bryostatin 2 into bryostatin 1 |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044419A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | WO2002044383A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044368A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044343A2 Tolerizing allografts of pluripotent stem cells |